Background. Although several studies have reported that kidney stone disease and hypertension are associated, the link between the two conditions has not been identified. This study investigated urinary excretion of different solutes, particularly citrate and acids, in kidney stone formers and examined their association with high blood pressure. Methods. The retrospective study included 234 consecutive subjects, aged 47.0 ± 15.6, attending our metabolic clinic after episodes of kidney stones. Essential hypertension was present in 82 patients (35.0%). A difference in the urinary excretion of some of the investigated components was found between subjects with normal blood pressure and those with hypertension. Results. The results showed that hypertensive subjects were older and had a higher body mass index (BMI) and serum uric acid. They had a significantly lower urinary pH (5.6 ± 0.4 versus 6.0 ± 0.5) and citrate (2.55 ± 1.36 versus 2.83 ± 1.65 mmol/24 h), higher titratable acid (38.8 ± 19.0 versus 26.8 ± 15.0 mEq/24 h) and ammonium (41.6 ± 17.6 versus 34.2 ±12.4 mmol/24 h). Logistic regression analysis with the presence of hypertension as the dependent variable produced a model with the following predictors: age (P < 0.0001), BMI (P = 0.026), titratable acid (P = 0.025) and low urinary citrate level (P = 0.033). Urinary acid excretion increased with the stage of hypertension. No difference was found in the urinary excretion of other solutes. Conclusions. These findings suggest that essential hypertension and acid excretion are linked in stone formers.
Introduction
Several studies have suggested that nephrolithiasis and hypertension are positively associated in humans and animals
Correspondence and offprint requests to: Attilio Losito, via Dei Mille 5, San Mariano, 06070 Perugia, Italy. Tel: +39-075-5782609; Fax: +39-075-5782566; E-mail: alosito3@gmail.com [1] [2] [3] . In humans, prior occurrence of nephrolithiasis significantly increases the risk of high blood pressure [4] ; metabolic studies show that patients with primary hypertension have a greater risk of renal stone formation [5, 6] .
Attention has concentrated on the association, and several hypotheses have been advanced. Predisposing factors such as female sex and excess body weight seem to be common features. Dietary factors like excessive salt and animal protein intake appear to play a role [7] . A common genetic basis linking high blood pressure to kidney stone formation has also been repeatedly proposed [8, 9] but not clearly demonstrated.
It has also been proposed that the link between hypertension and renal stone formation may lie in abnormal urinary concentrations of some lithogenic solutes: calcium, uric acid and oxalate [10, 11] . A recent report has suggested that hypertension and low urinary citrate levels may be associated in subjects without kidney stones [12] . The link between decreased citrate urinary excretion and altered renal handling of acids is well recognized, but the association with hypertension in stone formers has not been studied [13] .
The present study investigated whether hypocitraturia and increased acid excretion are associated in kidney stoneforming subjects with high blood pressure. The study was performed in an appropriately sized sample population of stone formers, who underwent a full metabolic assessment.
Patients and methods
This retrospective cohort study included data from 234 patients (136 males), who were consecutively enrolled in a metabolic study while attending our renal stone clinic.
All patients met the inclusion criteria of either three renal stone episodes in the previous 5 years or one episode per year in the last 3 years. Clinical examination and standard tests ruled out systemic diseases and secondary hypertension. Accurate anamnesis ruled out the use of medications responsible for 'drug-induced' kidney stones. All patients underwent a sonographic examination of the kidneys before the metabolic assessment, and the presence of any sign of obstructive nephropathy was considered an exclusion criteria.
Office blood pressure was repeatedly measured by a physician with a mercury sphygmomanometer following the recommendations of the European Society of Hypertension and classified according to the JNC 7 [14, 15] . The reported values are those obtained and recorded for each patient at the time of the detection of arterial hypertension. The class and the number of antihypertensive drugs were recorded. All drug treatments were suspended 3 days before the beginning of the metabolic study. Diuretics were stopped 1 week before to allow a full washout of their effects on body volumes, blood and urine components [16] . Patients were instructed to maintain their normal lifestyle and diet. Each patient received a container for a 24-h urine collection. On Day 2 of the study, blood samples were drawn from a forearm vein, a 2-h urine collection was performed for creatinine, calcium and citrate for separate analysis of relative ratios and a sample of the 24-h urine collection was sent for chemical analysis. The 2-h urine collection was used for the metabolic assessment under 'laboratory' conditions and to avoid mistakes in home urine collection. The 24-h collection was used for the study of the patients under everyday conditions. Subjects were asked not to change their eating and drinking habits. No dietetic analysis was performed. The BMI was determined as an index of fatness and obesity. Dietary protein intake was assessed by normalized urinary nitrogen appearance (nUNA) [17] .
The metabolic assessment was based on a full blood chemistry profile and urinary solute measurements. Blood and urine chemistry included nitrogen, creatinine, uric acid, sodium, potassium chloride, calcium, magnesium and phosphate, as measured by an automatic analyser (Shimadzu CL 300). Body weight was used for normalization of urinary solutes. Body surface area (BSA) was used for indexing creatinine clearance to 1.73 m 2 and was calculated by the formula of Du Bois and Du Bois. Parathyroid hormone was measured by chemiluminescence (Immunolite 2000-Medical System).
Urinary stone risk was evaluated in urine on the basis of the following parameters: volume, pH (pH meter), titratable acids (NaOH titration), ammonium (colorimetric assay) sulphate (turbidimetric assay), oxalate (enzymaticcolorimetric assay), citrate (UV assay). Urine supersaturation (SS) with respect to calcium oxalate (CaOx), uric acid (UA) and brushite (Br) was calculated using the 'LithoRisk' program [18] . Normal values for SS were CaOx <5, UA <1 and Br <2 [19] .
Statistics
Data are expressed as mean ± standard deviation (SD). ANOVA and the Student's t-test were used to compare the means of values between groups of subjects. The general linear method (GLM) and univariate and multivariate procedures were used for the analysis of the association between hypertension and the different variables. Differences among means of chosen variables in hypertensive and normotensive subjects were also evaluated with post hoc tests (Bonferroni). The model also estimated the marginal means of the different variables (averaged across all levels of the covariates such as age, BMI and body weight). A logistic regression (forward stepwise) was performed to select the variables predicting the presence of hypertension. Sex, age, body weight, BMI and urinary pH, titratable acid, calcium, citrate, oxalate, phosphate, sulphate and sodium were first analysed separately, and then entered in a stepwise way into the model as covariates. Age, body weight and BMI were also examined in the model for their interaction with urinary variables.
The commercial software SPSS 13.0 was used to perform the statistical analysis.
Results
Demographics and clinical characteristics of the 234 renal stone formers are shown in Table 1 . In 88 patients (37.6%), chemical analysis of the stone was not available. Stone compositions were CaOx monohydrate (51), CaOx dehydrate (22) , CaOx-UA (25), CaOx-calcium apatite (11), calcium apatite (7), UA (22) , struvite (4), Br (3) and ammonium urate (1) . One female patient with struvite stones had a positive clinical history for chronic urinary infection.
Urine SS for CaOx was found in 99 subjects, for Br in 88 and for UA in 66. Calciuria >0.1 mmol/kg/24 h was present in 45 subjects.
Systemic hypertension (JNC7 stages 2 and 3) was detected in 82 patients (35.0%), 48 of whom were males (35.2%) and 34 females (34.6%). Antihypertensive treatment was being administered to 79 patients (23 subjects took diuretics) with an average number of drugs of 1.5 ± 0.6. A pre-hypertension stage was present in 54 subjects (23%). In 98 patients blood pressure was normal.
Hypertensive and normotensive subjects were investigated for differences in clinical characteristics, demographics and urinary solute excretion. No difference was found in the length of stone history between the two groups. Age, body weight and BMI were higher in hypertensive subjects (Table 2 ). Serum concentration of UA was higher in hypertensive patients (t = 4.17, P < 0.001) ( Table 2) .
Patients with hypertension showed a lower excretion of citrate, a lower pH and higher excretion of titratable acids, ammonium and sulphate ( Table 2 ). The difference in the urinary excretion with normotensive subjects remained statistically significant also in multivariate analysis (GLM). In the analysis, age, nUNA and BMI were first tested separately and then entered in the multivariate analysis (Table 3) .
We made a comparison of the mean values of urinary pH, titratable acids, ammonium and sulphate between subjects with normal blood pressure, pre-hypertension, stage 1 and stage 2 hypertension, and we found significant differences (Figure 1) . The statistical significance of the difference was assessed by the Bonferroni test for multiple comparisons. With this analysis, the difference was significant for pH (F = 2.807, P < 0.05) and titratable acids (F = 2.625, P < 0.05).
The logistic regression with the presence of hypertension as a dependent variable produced a significant model (chi-square 74.709, P < 0.0001) indicating the following variables as predictors of hypertension: age (P < 0.0001, RR 1.074, 95% CI 1.047-1.101), BMI (P = 0.026, RR 1.096, 95% CI 1.043-1.218), titratable acid (P = 0.025, RR 1.028, 95% CI 1.003-1.052) and low urinary citrate concentration (P = 0.045, RR 0.730, 95% CI 0.547-0.989).
The analysis of components in the 2-h urine collection showed that the excretion of citrate was lower in hypertensive than in normotensive patients: 0.16 ± 0.10 mmol versus 0.21 ± 0.16 mmol. No other differences in solute excretion were observed.
In the group of patients with available chemical analysis of stones (146), UA alone or in combination with other components was present in stones of 48 subjects. The presence of UA in stones was 42% in stone formers with hypertension versus 22% in normotensive subjects (chi-square 4.317, P = 0.0377). Other components of stones did not present significant differences between groups.
Serum potassium and chloride were comparable between normotensive and hypertensive subjects.
The dietary protein intake, estimated by nUNA, is shown in Table 1 . In 58 subjects (24%), the estimated daily protein intake was >1.093 (third quartile). No significant differences were found in nUNA between hypertensive and normotensive subjects. No difference was found between the different groups of antihypertensive drug and diuretics with respect to urinary concentrations of acids and solutes.
Discussion
Our study confirms a high prevalence of hypertension in renal stone formers. The new finding is that in a population of stone formers, essential hypertension is associated with a lower urinary citrate and higher acid excretion. In a sample of the general population, body size and urinary pH were reported to be inversely related [20] . In our patients with high blood pressure BMI, urinary concentrations of hydrogen ions and titratable acids were higher than in normotensive subjects. The urinary excretion of these solutes also increased with the stage of hypertension.
In females with high BMI, an association between nephrolithiasis and increased blood pressure has recently been reported [21] . While we confirm the increase in BMI is associated with high blood pressure, female gender played no role in our model.
In our cohort of stone formers, urinary excretion of calcium was not different in normotensive and hypertensive findings that are at variance with the report of a link between high urinary calcium and familial hypertension in stone formers [11] . The high serum UA and the increased prevalence of UA stones in the group with hypertension, we found in this study, are in keeping with the lower urinary pH of hypertensive subjects, and the low urinary citrate in this group of patients may be the consequence of an increased metabolic production of acid [12] . The finding of hyperuricaemia in hypertension is not new [22] . Its cause has not been fully elucidated although an association with an abnormality of the metabolism of lactic acid has been suggested [20] . With regard to diet, although we have not found a difference in nUNA, indicating a different protein intake, the higher sulphate excretion might indicate a higher intake in animal proteins, that are high in sulphate, with an overall normal protein content. The lack of a proper dietetic analysis does not allow us to draw conclusions in this connection. Whereas a hypothetical increase in animal protein intake might account for an increase in urinary acid excretion, it does not explain how this corresponds to the degree of hypertension or to the low citrate excretion. Urine was collected on a normal working day, with the aim of examining the average daily intake of nutrients. Nonetheless, under test conditions, a different diet might have been adopted. This difference and even eventual mistakes in urinary collection at home cannot explain increased acid excretion in hypertensive subjects and the difference between different degrees of hypertension. Furthermore, in the 2-h urine collection, citrate, during the metabolic study, was confirmed to be lower in hypertensive patients.
The association between low citrate, high titratable acid and high BMI with hypertension may indicate two underlying mechanisms. The first links hypertension to body mass with increased acid excretion as a collateral finding. The other suggests that increased acid excretion and related low urinary citrate level are markers of subclinical acidosis or an altered acid excretion mechanism. A possible association between hypertension and altered acid-base state is supported by experimental evidence. In animal models of hypertension, metabolic acidosis and increased acid excretion were found before the development of hypertension [23] . In two strains of spontaneously hypertensive rats, plasma pH and bicarbonate concentration were lower than those in normotensive controls [24] . Furthermore, salt sensitivity seems to be associated with increased metabolic acid production in animals and humans [25, 26] . Therefore, stone forming may, like salt sensitivity, predispose to hypertension.
In conclusion, despite its limitations, this cross-sectional study shows high urinary acid excretion in renal stone formers with hypertension increasing with the stage of hypertension and suggests that a metabolic imbalance may be responsible. Renal and metabolic mechanisms underlying this association deserve specially designed investigations.
